US HB5391 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on September 12 2023 - 25% progression, died in committee
Action: 2023-09-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 12 2023 - 25% progression, died in committee
Action: 2023-09-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation.
Title
Protecting Patient Access to Cancer and Complex Therapies Act
Sponsors
Rep. Michael Burgess [R-TX] | Rep. Greg Murphy [R-NC] | Rep. Pete Sessions [R-TX] | Rep. Dan Crenshaw [R-TX] |
Rep. Neal Dunn [R-FL] |
History
Date | Chamber | Action |
---|---|---|
2023-09-15 | House | Referred to the Subcommittee on Health. |
2023-09-12 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2023-09-12 | House | Introduced in House |
Same As/Similar To
SB2764 (Related) 2023-09-12 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/5391/all-info |
Text | https://www.congress.gov/118/bills/hr5391/BILLS-118hr5391ih.pdf |